Trifluorothymidine Resistance Is Associated with Decreased Thymidine Kinase and Equilibrative Nucleoside Transporter Expression or Increased Secretory Phospholipase A2Olaf H. Temmink, Godefridus J. Peters, Irene V. Bijnsdorp et al.|Molecular Cancer Therapeutics|2010Cited by 30
Lipophilic Prodrugs and Formulations of Conventional (Deoxy)Nucleoside and Fluoropyrimidine Analogs in CancerGodefridus J. Peters, Marit Liland Sandvold, Auke D. Adema et al.|Nucleosides Nucleotides & Nucleic Acids|2011Cited by 13
Supplementary Data from Trifluorothymidine Resistance Is Associated with Decreased Thymidine Kinase and Equilibrative Nucleoside Transporter Expression or Increased Secretory Phospholipase A2Olaf H. Temmink, Godefridus J. Peters, Irene V. Bijnsdorp et al.|Unknown|2023Cited by 0
Supplementary Data from Trifluorothymidine Resistance Is Associated with Decreased Thymidine Kinase and Equilibrative Nucleoside Transporter Expression or Increased Secretory Phospholipase A2Olaf H. Temmink, Godefridus J. Peters, Irene V. Bijnsdorp et al.|Unknown|2023Cited by 0
Data from Trifluorothymidine Resistance Is Associated with Decreased Thymidine Kinase and Equilibrative Nucleoside Transporter Expression or Increased Secretory Phospholipase A2Olaf H. Temmink, Godefridus J. Peters, Irene V. Bijnsdorp et al.|Unknown|2023Cited by 0